Finance

Beta
Lists
AMN:NYSE
AMN Healthcare Services Inc
$32.76
+1.33%
(+0.43) 1D
$33.77
+3.10% (+1.01)
After hours
Closed: Jun 26, 4:00:11 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMN...
Open
$32.64
High
$33.48
Low
$31.90
Mkt. cap
1.27B
Avg. vol.
1.08M
Volume
1.97M
52-wk high
$33.48
52-wk low
$14.86
EPS
-$0.88
Beta
0.44
Shares outstanding
38.79M
No. of employees
3K
Open
$32.64
High
$33.48
Low
$31.90
Mkt. cap
1.27B
Avg. vol.
1.08M
Volume
1.97M
52-wk high
$33.48
52-wk low
$14.86
EPS
-$0.88
Beta
0.44
Shares outstanding
38.79M
No. of employees
3K
News stories
From sources across the web
About AMN Healthcare Services Inc
CEOCary Grace
Employees2.66K
Founded1985
Headquarters-
SectorHealth care provider
Websiteamnhealthcare.com
Analyst ratings
Based on 6 analysts giving stock ratings to AMN in the past 3 months
Hold
Buy
2
Hold
3
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AMN in the last 3 months.
Highest
Current $32.76
$32.00 (-2.32%)
Average
$26.50 (-19.11%)
Lowest
$22.00 (-32.84%)
Analyst
Recommendation
Action
Price target
Projected
Date
Trevor Romeo
William Blair
Hold
Maintained
-
-
06/03/2026
Tobey Sommer
Truist Financial
Buy
Maintained
-
-
05/19/2026
Joanna Gajuk
Bank of America Securities
Sell
Reiterated
$22.00
-32.8%
05/14/2026
A.J. Rice
UBS
Hold
Maintained
$32.00
-2.3%
05/13/2026
Mark Marcon
Robert W. Baird
Hold
Maintained
$26.00
-20.6%
05/11/2026
Jeffrey Silber
BMO Capital
Buy
Maintained
$26.00
-20.6%
05/08/2026
Constantine Davides
Citizens JMP
Buy
Maintained
$24.00
-26.7%
02/23/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$2.10 / $1.62
+29.87%beat
Revenue / Est. (USD)
1.38B / 1.23B
+11.74%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
658.18M
634.50M
748.22M
1.38B
Cost of goods sold
461.78M
450.08M
553.10M
1.01B
Cost of revenue
461.78M
450.08M
553.10M
1.01B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
154.58M
138.59M
152.11M
218.42M
Operating expense
192.34M
175.97M
186.97M
251.66M
Total operating expenses
654.11M
626.06M
740.06M
1.26B
Operating income
4.06M
8.44M
8.16M
117.17M
Other non operating income
-
-
-
-
EBT including unusual items
-135.08M
37.99M
-4.16M
110.46M
EBT excluding unusual items
-7.30M
-1.19M
-4.12M
110.46M
Income tax expense
-18.87M
8.70M
3.53M
48.29M
Effective tax rate
13.97%
22.91%
-84.91%
43.72%
Other operating expenses
-
-
-
-
Net income
-116.20M
29.29M
-7.70M
62.17M
Net profit margin
-17.66%
4.62%
-1.03%
4.51%
Earnings per share
0.30
0.39
0.22
2.10
Interest and investment income
-
-
-
-
Interest expense
-11.36M
-9.63M
-12.28M
-6.71M
Net interest expenses
-11.36M
-9.63M
-12.28M
-6.71M
Depreciation and amortization charges
37.75M
37.38M
34.85M
33.24M
EBITDA
43.95M
48.07M
45.39M
152.83M
Gain or loss from assets sale
18.27M
-39.18M
46.00K
3.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of AMN
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer